Cuba studied 21,399 samples for COVID 19, resulting in 1,060 positive ones. The country accumulates 3, 256,543 samples taken and 88,445 positive.
Cuba reports 1,060 new cases of COVID 19, 1,187 discharges and nine deaths
Cuba Guarantees Free Assistance to all the Physically Challenged
Cuban Foreign Minister Bruno Rodriguez stressed the assistance of all physically challenged persons on the island, while in today’s world those citizens face lots of difficulties.
Phase II clinical trial of vaccine candidate Soberana Plus to include 450 COVID 19 convalescents
The Phase II clinical trials of Soberana Plus in convalescents of COVID 19 will include 450 people and will broaden the inclusion criteria compared to Phase I, informed today an expert from the Finlay Vaccine Institute (IFV), the entity that developed this vaccine candidate against COVID-19.
Cuban COVID-19 Vaccines Keep Progressing
Experts with the BioCubaFarma Biotech conglomerate said on Monday that the second dose of the locally developed COVID-19 vaccines Soberana 02 and Abdala keep advancing as scheduled.
Cuba reports 854 new cases of COVID 19, 1,095 discharges and eight deaths
Cuba studied 21,799 samples for COVID 19, resulting in 854 positive ones. The country accumulates 3,235,144 samples taken and 87,385 positive.
Cuban eastern province decreases premature mortality due to breast cancer
Thanks to the opportune assistance of patients and the active work of specialized medical personnel, premature mortality due to breast cancer has been reduced in Santiago de Cuba.
Cuban health authorities warn of high number of Covid-19 cases in pediatric patients
The country accumulates 10,766 cases of people diagnosed with Covid-19 in pediatric ages, an extremely high figure, according to Cuban experts, which is why they are calling attention to this phenomenon.
Application of first anti-Covid-19 dose to health workers and Biocubafarma is completed.
Health personnel from Havana and Biocubafarma, participating in the intervention study of Soberana 02 and Abdala, two of Cuba's anti-COVID-19 candidates, are currently vaccinated with the first dose.
Cuba has biomolecular laboratories in almost every province
With the inauguration this Saturday of the Laboratory of Molecular and Cellular Biology in Las Tunas, almost all Cuban provinces now have facilities of this type for the processing of samples for the detection of COVID-19 and the study of other specialties such as Oncology and Genetics.
Soberana Plus vaccine candidate to start Phase II clinical trial
Cuba's Center for State Control of Medicines, Equipment and Medical Devices (CECMED) approved the Phase II clinical trial of the Cuban anti-COVID-19 vaccine candidate Soberana Plus.
I Put all my Hopes on this Vaccine, says Just Vaccinated Cuban
Georgina Igarza is a Cuban woman living in eastern Santiago de Cuba city who volunteered herself to take part in the phase II trials of the Abdala Covid-19 candidate vaccine; she said she fully trusts the Cuban health system and scientists since they struggle for the wellbeing of the people.
UNCTAD highlights Cuba's struggle against COVID-19
The Cuban State’s efforts to tackle COVID-19 without renouncing its socioeconomic development plans in the midst of an intensified U.S. blockade were praised in the first of a series of online meetings leading up to 15th United Nations Conference on Trade and Development (UNCTAD), to be held on October 3-8 in Barbados.
Presence of new SARS-CoV-2 strains confirmed in eastern Cuba
Two new genetic variants of SARS-CoV-2, initially identified in South Africa and California, are circulating in the Cuban province of Matanzas, Fernando Acebo Figueroa, director of the local unit of Hygiene, Epidemiology and Microbiology confirmed last night.
Cuba greeted 2021 with more than 100 clinical trials
Cuba entered the year 2021 with 101 clinical trials led by the National Coordinating Center for Clinical Trials (CENCEC), 46% of them linked to the fight against cancer.
Cuba boasts stomatological indicators on a par with those of developed countries
Cuba entered the year 2021 with stomatological indicators similar to those of developed nations, despite the impact of the COVID-19 pandemic and the intensification of the U.S. economic, commercial and financial blockade.